AUDECOM
Oscilla A30
Oscilla A50
Oscilla A60
Snoring keeping you (and others) up? It could be Sleep Apnea.
Meet iNAP - FDA - Approved, Mask-Free Sleep Therapy Transforming OSA Care, which gives you a safe, proven way back to restful nights.
Know More
About Us
Contact
Awards & Recognition
Careers
Clinic Installations
Compliance Wall
Global Presence
Leadership
Events
Discover Our Global Presence
From India to emerging and established healthcare markets across USA and Bangkok — Taevas Life Sciences is expanding its footprint with innovative medical technologies and trusted partnerships that redefine clinical care standards worldwide.
Know More
Healthcare ProfessionalsExplore clinically validated tools, protocols, and insights designed to support accurate diagnosis, treatment, and research across vestibular, audiology, and sleep therapy domains.
PatientsUnderstand your condition better and make informed care decisions with our educational resources, therapy guides, and real-world success stories.
Blog & Clinical Articles
Case Studies
Infographics
Testimonials
Training Resources/Manuals
Videos Gallery
Whitepapers
Webinars
Do You Snore or Wake Up Tired?
Register now
Balance LabBalance Lab is a one stop solution that can deliver comprehensive diagnosis for balance disorders.
NexusNEXUS connects clinicians, patients, and devices into one secure workflow for faster, smarter care.
Expand your portfolio with innovation that delivers
Empower clinics and hospitals across India and global markets with Taevas's clinically validated medical devices in ENT, neurology, audiology, sleep therapy, and imaging. Join a trusted network of healthcare distributors backed by marketing support, CME training, and global fulfillment.
Know More
Co-create, and scale medtech innovations globally
Bring your medtech innovation to life with Taevas — your commercialization partner for India and beyond. We collaborate with global manufacturers, digital health firms, and innovators to localize, validate, and scale breakthrough technologies through regulatory support, clinical trials, and nationwide distribution.
Know More
DistributorsEmpower clinics and hospitals across India and global markets with Taevas’s clinically validated medical devices in ENT, neurology, audiology, sleep therapy, and imaging.
ManufacturersBring your medtech innovation to life with Taevas — your commercialization partner for India and beyond.
Expand your portfolio with innovation that delivers
Empower clinics and hospitals across India and global markets with Taevas's clinically validated medical devices in ENT, neurology, audiology, sleep therapy, and imaging.Join a trusted network of healthcare distributors backed by marketing support, CME training, and global fulfillment.
Know More
Co-create, and scale medtech innovations globally
Bring your medtech innovation to life with Taevas - your commercialization partner for India and beyond. We collaborate with global manufacturers, digital health firms, and innovators to localize, validate, and scale breakthrough technologies through regulatory support, clinical trials, and nationwide distribution.
Know More

HCP Case Studies

CPAP-Intolerant Professional Achieves Restful Sleep

Editorial TeamJanuary 7, 2026

Download the case study CPAP-Intolerant Professional Achieves Restful Sleep (opens in a new tab)

A CPAP-intolerant professional with moderate obstructive sleep apnea achieved meaningful clinical improvement following iNAP oral negative-pressure therapy. Treatment resulted in sustained nightly adherence, reduced apnea severity, improved daytime alertness, and enhanced sleep continuity. This real-world case highlights iNAP’s potential as a comfortable, mask-free alternative for patients unable to tolerate CPAP.

From the case study

PPTX

CPAP-Intolerant Professional Achieves Restful Sleep

Download the case study

More case studies

All case studies

iNap Case Study 4

HCP Case Studies

Oral Pressure Therapy (OPT) in Obstructive Sleep Apnea

MRI-based evaluation of OPT demonstrated significant anatomical airway changes in obstructive sleep apnea responders. OPT enlarged the retropalatal airway through anterior displacement of the soft palate, resulting in marked apnea–hypopnea index reduction. These mechanistic findings support OPT as a targeted, anatomy-driven alternative for selected patient's intolerant of CPAP.

Editorial TeamFeb 3, 2026

iNap Case Study 3

HCP Case Studies

Successful OSA Symptom Control - iNAP

Mandibular advancement oral appliance therapy provided effective symptom control in a CPAP-intolerant obstructive sleep apnea patient. Clinical evidence shows meaningful reductions in apnea severity, improved daytime symptoms, and high long-term adherence. Despite less AHI reduction than CPAP, superior nightly usage supports oral appliances as a practical alternative for selected OSA patients.

Editorial TeamFeb 3, 2026

iNap Case Study - 11

HCP Case Studies

Single-Night Feasibility Study of Mask-Free Therapy

A single-night feasibility study evaluated mask-free intraoral negative-pressure therapy in obstructive sleep apnea patient's intolerant to CPAP. Results demonstrated significant reductions in apnea–hypopnea index, improved oxygenation, and enhanced sleep continuity. Rapid polysomnography-based assessment enabled early responder identification, supporting oral negative-pressure therapy as a practical, non-invasive alternative for selected patients.

Editorial TeamJan 7, 2026